trending Market Intelligence /marketintelligence/en/news-insights/trending/x-7Xp_tMGBVnydmvHXyJRA2 content esgSubNav
In This List

Allergan completes $2.9B LifeCell acquisition

Blog

Banking Essentials Newsletter: 7th February Edition

Case Study

A Bank Outsources Data Gathering to Meet Basel III Regulations

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)

Blog

Essential IR Insights Newsletter Fall - 2023


Allergan completes $2.9B LifeCell acquisition

Allergan PLC acquired LifeCell Corp. for approximately $2.9 billion in cash.

The acquisition adds LifeCell's portfolio of reconstruction and complex hernia surgery products to Allergan's existing portfolio of medical aesthetic products, breast implants and tissue expanders.

The merger will also give Allergan access to LifeCell's manufacturing and R&D operations in New Jersey.

Guggenheim Securities and Barclays served as financial advisors to Allergan, while Debevoise & Plimpton LLP were Allergan's lead legal counsel.